MedPath

Effectiveness and Safety of the Nursing Prescription in Acute Health Problems of Low Complexity

Not Applicable
Conditions
Acute Disease
Registration Number
NCT03892850
Lead Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Brief Summary

Objective: To compare the efficacy/effectiveness of pharmacological nurse prescription with medical prescription in patients attended in a primary care center for minor acute health problems.

Scope of the study: Multicenter study, with the participation of 8 primary care centers of Catalonia.

Methodology: Randomized blind clinical trial, with experimental group receiving pharmacological nurse prescription and a control group receiving medical prescription. Subjects are individuals who request a same day consultation for minor acute pathologies and meet the selection criteria, with random assignment of 374 subjects, 187 per group.

The efficacy/effectiveness of the prescribed treatment will be considered as a no re-attendance during the following 72h and will be completed with the variables: information and knowledge of the treatment, adverse effects, compliance, satisfaction level and resolution of the health problem. The data collection is done 10 days after the visit by an ad-hoc telephone questionnaire of 11 items, previously tested. The analysis is done using the SPSS software version 21.0, obtaining data of descriptive, multivariate and inferential statistics.

Implications for practice: To evidence the equivalence of pharmacological nurse prescription with medical prescription for minor acute health problems

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
374
Inclusion Criteria
  • Contusion
  • Diarrhea / vomit
  • Fever without focality
  • Flu
  • Urinary distress
  • Odinophagy
  • Toothache
  • Skin Bite
  • Upper respiratory symptoms
  • Ankle twist
Exclusion Criteria
  • Language barrier
  • Cognitive deterioration
  • Sensory deficit
  • Pregnancy
  • Immunosuppression
  • Neoplasia in the last 5 years
  • Does not participate / Does not sign consent
  • Breastfeeding period
  • Reconsult
  • Resides outside of Spain
  • Treatment with glucocorticoids in the last 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
no re-attendance during the following 72 hoursDuring next 72 hours

Options: Yes / No

Secondary Outcome Measures
NameTimeMethod
satisfaction levelafter 10 days

Options of survey: Very satisfied, satisfied, ok, dissatisfied, very dissatisfied

complianceafter 10 days

Options: Yes / No (Reason for answered no: Appearance of side effects, Disappearance of symptoms, Distrust of tto, Complicated dosage, No improvement of symptoms, I forget)

resolution of the health problemafter 10 days

Options of survey: Fully resolved, Very resolved, Something solved, A little resolved, Nothing solved

Level of information and knowledge of the treatmentafter 10 days
adverse effectsafter 10 days

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.